| Name |
Tardyferon 20 mg/ml oralna otopina |
| Marketing Authorisation Number |
HR-H-440074818 |
| Active Substance |
željezov(II) sulfat heptahidrat |
| Composition |
1 ml oralne otopine sadrži 20 mg željeza u obliku željezovog(II) sulfata heptahidrata |
| Pharmaceutical Form |
Oralna otopina |
| Manufacturer |
Pierre Fabre Medicament Production, Gien, Francuska |
| Marketing Authorisation Holder |
Pierre Fabre Medicament, Les Cauquillous, Lavaur, Francuska |
| Marketing Authorisation Date |
19.07.2023 |
| MA Period of Validity |
19.07.2028 |
| Classification Number |
UP/I-530-09/23-01/04 |
| Registration Number |
381-12-01/286-23-08 |
| Prescription |
na recept |
| Type of prescription |
ponovljivi recept
|
| Distribution |
u ljekarni |
| Advertising to general public |
zabranjeno |
| ATC Code |
B03AA07 |
| SmPC |
download |
| PL |
download |
| Public Assessment Report |
download
|
